Literature DB >> 10051507

Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver.

J G de la Asunción1, M L del Olmo, J Sastre, F V Pallardó, J Viña.   

Abstract

Zidovudine (3'-azido-2',3'-dideoxythymidine [AZT]) inhibits human immunodeficiency virus replication and delays progression of acquired immune deficiency syndrome. We have recently found that, in muscle, AZT causes oxidative damage to mitochondrial DNA (mtDNA) and other signs of mitochondrial oxidative damage. The aim of this work was to test if AZT causes oxidative damage to liver mtDNA. In our study, an experimental mouse model was used in which mice were administered AZT (10 mg/kg body weight/d) in drinking water. Liver mtDNA of mice treated with AZT had 40% more of the oxidized, mutagenic nucleoside, 8-oxo-7,8-dihydroxy-2'deoxyguanosine (8-oxo-dG) than untreated controls. This oxidative damage to mtDNA is caused by a significant increase (of over 240%) in peroxide production by liver mitochondria from AZT-treated mice, which was prevented by dietary administration with vitamins C and E.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051507     DOI: 10.1002/hep.510290353

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.

Authors:  Pinghu Zhang; Luyong Zhang; Zhenzhou Jiang; Yating Xiong; Hongkui Chen; Yuanqing Tao; Maozhi Hu; Zhan Li
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 3.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

4.  Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.

Authors:  Smita S Ghare; Hridgandh Donde; Wei-Yang Chen; David F Barker; Leila Gobejishvilli; Craig J McClain; Shirish S Barve; Swati Joshi-Barve
Journal:  Toxicol In Vitro       Date:  2016-05-26       Impact factor: 3.500

Review 5.  Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?

Authors:  G Moyle
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

6.  Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.

Authors:  Gabriel Birkus; Michael J M Hitchcock; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors.

Authors:  S Moretti; S Marcellini; A Boschini; G Famularo; G Santini; E Alesse; S M Steinberg; M G Cifone; G Kroemer; C De Simone
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

8.  Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.

Authors:  Kaleb C Lund; LaRae L Peterson; Kendall B Wallace
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

9.  Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Authors:  Mariana Gerschenson; Courtney Kim; Baiba Berzins; Babafemi Taiwo; Daniel E Libutti; Julia Choi; Diana Chen; Jill Weinstein; Jessica Shore; Barbara da Silva; Elizabeth Belsey; Grace A McComsey; Robert L Murphy
Journal:  J Antimicrob Chemother       Date:  2009-03-25       Impact factor: 5.758

10.  Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.

Authors:  Atrayee Banerjee; Mohamed A Abdelmegeed; Sehwan Jang; Byoung-Joon Song
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.